CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, Gard, 30029, France
NCT Number: NCT01292044
The primary objective of this study is to evaluate the role of elastography (along with echographic and cytological data) as a diagnostic tool for thyroid cancer
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Nîmes, Gard, 30029, France
Ultrasound is considered the first line examination in the exploration of the thyroid nodule. Echotexture analysis often identifies nodules at risk of malignancy, but does not replace or exclude an additional cytological exploration. Cytology, although effective, also has limitations, particularly when samples are vesicular and it is difficult discern between a benign or malignant state. The creation of a noninvasive method in this context could help to avoid invasive tests or "useless" surgical procedures.
Ultrasound elastography, which assesses tissue deformability, may provide valuable information concerning benign soft tissue characteristics, whereas malignant lesions are harder in consistency. Interest in this method, already proposed for other organs, has recently increased due to the emergence of specifically created software that enables objective evaluation of the hardness of the nodule during a conventional ultrasound analysis. The main hypothesis of this study is that elastography should allow better selection of candidates for thyroid surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A conventional thyroid echography performed before a the time of fine needle aspiration will include elastographic measurements for each node under study.
Time frame: 15 days
Areas under the curves are estimated using the Wilcoxon-Mann-Chitney statistic. The gold standard is determined by anatomopathological examination of the excised tumor.
Centre Hospitalier Universitaire de Nīmes
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02208544
Endocrine Gland Neoplasms, Endocrine System Diseases
Nijmegen, Gelderland, Netherlands
View Trial DetailsNCT03469310
Agnosia, Chemically-Induced Disorders
Edinburg, Texas, United States
View Trial DetailsNCT03031639
Endocrine Gland Neoplasms, Endocrine System Diseases
Muang, Khonkaen, Thailand
View Trial DetailsNCT03547648
Endocrine Gland Neoplasms, Endocrine System Diseases
Istanbul, Turkey (Türkiye)
View Trial Details